1[1]Hopfinger AJ.A QSAR investigation of dihydrofolate reductase inhibition by baker trizaines based upon molecular shape analysis[J],J Am Chem Soc,1980,102(24):7196-7206.
2[2]Contreras ML,Gonzalez FD,Munoz VC,et al. Computer assisted molecular design and biophore determination. Application to AIDS drugs[J]. Bol Soc Chil Quim,1995, 40(3):279-291.
3[3]Crippen GM.Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors[J]. J Med Chem,1980,23(6):599-606.
4[4]Cramer III RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins[J].J Am Chem Soc,1988,110(18): 5959- 5967.
6[6]Ferguson AM, Heritage T, Jonathon P, et al.EVA: a new theoretically based molecular descriptor for use in QSAR/QSPR analysis[J].J Comput Aided Mol Des, 1997,11(2):143-152.
7[7]Gancia E, Bravi G, Mascagni P, et al. Global 3D-QSAR methods: MS-WHIM and autocorrelation[J],J Comput Aided Mol Des, 2000,14(3):293-306.
8[8]Klebe G, Abraham U, Mietzner T.Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity[J]. J Med Chem, 1994,37(24):4130-4146.
9[9]Pastor M, Cruciani G, McLay I, et al.GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors[J].J Med Chem, 2000,43(17):3233-3243.
10[10]Verli H, Albuquerque MG, de Alencastro RB,et al.Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands[J].Eur J Med Chem, 2002,37(3):219-229.
